China-EU Exchange: COVID-19 Perspectives From the Frontlines on Patient and Hospital Management
Published: 16 April 2020
-
Views:
293
-
Likes:
7
-
Views:
293
-
Likes:
7
-
Part 2 | Session 1 Principles of Prevention
-
Part 3 | Session 1 Clinical Characteristics and Management
-
Part 4 | Session 1 Summary and Closing Remarks
Overview
This webinar was developed by a collaboration between Boston Scientific, the British Cardiovascular Intervention Society (BCIS) and supported by Millbrook Medical Conferences and Radcliffe Cardiology. It brings together leading physicians from China and the UK with the aim to share knowledge, experience and learnings of the COVID-19 pandemic, including in-depth discussion regarding its characteristics, and management for its prevention and control.

Educational objectives
- Understand the Approaches Taken for Infection Management in China
- Compare and Contrast Strategies for Management in Both the Wider Population and in a Clinical Setting
- To Enhance Knowledge of Treatment Strategies and Options Available
More from this programme
Part 1
Introduction and Opening Address
1 session | |
Introduction and Opening Address | Watch now |
Part 2
Principles of Prevention
1 session | |
Principles of Prevention | Watch now |
Part 3
Clinical Characteristics and Management
Part 4
Summary and Closing Remarks
1 session | |
Summary and Closing Remarks | Watch now |
Faculty Biographies

Nick Curzen
Prof Curzen is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3) and joined the editorial board in November 2021.
Prof Nick Curzen (BM (hons) PhD FRCP) is a Professor of Interventional Cardiology at the University of Southampton and Honorary Consultant Cardiologist at the University Hospital Southampton NHS Foundation Trust. He is the current President of BCIS, having previously been a Council member, Education Lead, Research Lead and Honorary Secretary.
Nick specialises in coronary and aortic valve intervention.
He pursues an active research programme: Chief Investigator for RIPCORD2 and FORECAST randomised trials as well as for FFRCT RIPCORD & COMET. He also has active interests in platelet function, computer modelling of coronary stents and re-do TAVI implantation and coronary physiology. The research group contributes to many high…

Junbo Ge
Prof Junbo Ge, Academician of the Chinese Academy of Sciences, and Zhongshan Hospital, Fudan University, Shanghai, CN